FibroBiologics
(NASDAQ) FBLG
FibroBiologics Financials at a Glance
Market Cap
$4.74M
Revenue (TTM)
$0.00
Net Income (TTM)
$18.65M
EPS (TTM)
$-8.78
P/E Ratio
-0.15
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Price
$1.33
Volume
5,288
Open
$1.41
Price
$1.33
Volume
5,288
Open
$1.41
Previous Close
$1.33
Daily Range
$1.30 - $1.46
52-Week Range
$1.03 - $30.60
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Price
$1.33
Volume
5,288
Open
$1.41
Previous Close
$1.33
Daily Range
$1.30 - $1.46
52-Week Range
$1.03 - $30.60
FBLG News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout FibroBiologics
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
Peter O'Heeron
Website
www.fibrobiologics.comHeadquarters
Houston, DE 77598, US
FBLG Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-419%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-6.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.74M
Shares Outstanding
3.51M
Volume
5.29K
Short Interest
0.00%
Avg. Volume
313.01K
Financials (TTM)
Gross Profit
$832.00K
Operating Income
$16.65M
EBITDA
$17.61M
Operating Cash Flow
$16.39M
Capital Expenditure
$262.00K
Free Cash Flow
$16.66M
Cash & ST Invst.
$4.89M
Total Debt
$2.41M
FibroBiologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$234.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.74M
N/A
Market Cap/Employee
$364.79K
N/A
Employees
13
N/A
Net Income
$3.24M
-4.7%
EBITDA
$2.81M
+4.6%
Quarterly Fundamentals
Net Cash
$2.48M
-27.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.70M
+73.2%
Short Term Debt
$706.00K
-92.6%
Return on Assets
-1.94%
N/A
Return on Invested Capital
-2.12%
N/A
Free Cash Flow
$3.16M
+0.3%
Operating Cash Flow
$3.16M
-2.9%